Protein kinase CK2: a potential therapeutic target for diverse human diseases

C Borgo, C D'Amore, S Sarno, M Salvi… - Signal transduction and …, 2021 - nature.com
CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of
substrates, controls several signaling pathways, and is implicated in a plethora of human …

A comparative analysis of individual RAS mutations in cancer biology

C Muñoz-Maldonado, Y Zimmer, M Medová - Frontiers in oncology, 2019 - frontiersin.org
In human cells, three closely related RAS genes, termed HRAS, KRAS, and NRAS, encode
four highly homologous proteins. RAS proteins are small GTPases involved in a broad …

Strategies of targeting CK2 in drug discovery: challenges, opportunities, and emerging prospects

Y Chen, Y Wang, J Wang, Z Zhou, S Cao… - Journal of Medicinal …, 2023 - ACS Publications
CK2 (casein kinase 2) is a serine/threonine protein kinase that is ubiquitous in eukaryotic
cells and plays important roles in a variety of cellular functions, including cell growth …

CK2 regulation: perspectives in 2021

SE Roffey, DW Litchfield - Biomedicines, 2021 - mdpi.com
The protein kinase CK2 (CK2) family encompasses a small number of acidophilic
serine/threonine kinases that phosphorylate substrates involved in numerous biological …

Cell cycle checkpoint control in response to DNA damage by environmental stresses

JA Pedroza‐Garcia, Y Xiang, L De Veylder - The Plant Journal, 2022 - Wiley Online Library
Being sessile organisms, plants are ubiquitously exposed to stresses that can affect the DNA
replication process or cause DNA damage. To cope with these problems, plants utilize DNA …

Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy–potential clinical relevance

C D'Amore, C Borgo, S Sarno, M Salvi - Cellular Oncology, 2020 - Springer
Background Protein kinase CK2 inhibition has long been considered as an attractive anti-
cancer strategy based on the following considerations: CK2 is a pro-survival kinase, it is …

[HTML][HTML] The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer

D Lukanović, M Herzog, B Kobal, K Černe - Biomedicine & …, 2020 - Elsevier
Ovarian cancer has the highest mortality rate among all gynecologic cancers, with most
patients presenting with advanced stage tumors. About a third of patients do not respond to …

Targeting CK2 in cancer: a valuable strategy or a waste of time?

M Salvi, C Borgo, LA Pinna, M Ruzzene - Cell death discovery, 2021 - nature.com
CK2 is a protein kinase involved in several human diseases (ranging from neurological and
cardiovascular diseases to autoimmune disorders, diabetes, and infections, including …

Anticancer properties of chimeric HDAC and kinase inhibitors

B Biersack, S Polat, M Höpfner - Seminars in cancer biology, 2022 - Elsevier
Histone deacetylases (HDACs) are epigenetic regulators of chromatin condensation and
decondensation and exert effects on the proliferation and spread of cancer. Thus, HDAC …

Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment

E Schanknecht, A Bachari, N Nassar, T Piva… - International Journal of …, 2023 - mdpi.com
Melanoma is deadly, physically impairing, and has ongoing treatment deficiencies. Current
treatment regimens include surgery, targeted kinase inhibitors, immunotherapy, and …